These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

636 related articles for article (PubMed ID: 2471770)

  • 121. The CD85/LIR-1/ILT2 inhibitory receptor is expressed by all human T lymphocytes and down-regulates their functions.
    Saverino D; Fabbi M; Ghiotto F; Merlo A; Bruno S; Zarcone D; Tenca C; Tiso M; Santoro G; Anastasi G; Cosman D; Grossi CE; Ciccone E
    J Immunol; 2000 Oct; 165(7):3742-55. PubMed ID: 11034379
    [TBL] [Abstract][Full Text] [Related]  

  • 122. Identification of a human T cell clone with the cytotoxic T lymphocyte and natural killer-like cytotoxic function against autologous mammary carcinoma and K562 line.
    Sato T; Okubo M; Wada Y; Sato N; Kikuchi K
    Jpn J Cancer Res; 1989 Jul; 80(7):655-61. PubMed ID: 2507488
    [TBL] [Abstract][Full Text] [Related]  

  • 123. Human immune response to DNP-modified autologous cells after treatment with a DNP-conjugated melanoma vaccine.
    Sato T; Maguire HC; Mastrangelo MJ; Berd D
    Clin Immunol Immunopathol; 1995 Jan; 74(1):35-43. PubMed ID: 7994925
    [TBL] [Abstract][Full Text] [Related]  

  • 124. An analysis of autologous T-cell anti-tumour responses in colon-carcinoma patients following active specific immunization (ASI).
    Patel BT; Lutz MB; Schlag P; Schirrmacher V
    Int J Cancer; 1992 Jul; 51(6):878-85. PubMed ID: 1639535
    [TBL] [Abstract][Full Text] [Related]  

  • 125. Cytotoxic T cell recognition of a human melanoma derived peptide with a carboxyl-terminal alanine-proline sequence.
    Morioka N; Kikumoto Y; Hoon DS; Morton DL; Irie RF
    Mol Immunol; 1995 Jun; 32(8):573-81. PubMed ID: 7541891
    [TBL] [Abstract][Full Text] [Related]  

  • 126. CD4+ Th0 cell clones, isolated from a metastatic lymph node of a melanoma patient, possess cytolytic function.
    Imro MA; Castagneto C; Bosco O; Modena P; Lanza L; Puppo F; Filaci G; Indiveri F; Scudeletti M
    Cancer Immunol Immunother; 1995 Oct; 41(4):210-6. PubMed ID: 7489563
    [TBL] [Abstract][Full Text] [Related]  

  • 127. Clonal analysis of T lymphocyte response to an isolated class I disparity.
    Reinsmoen N; Anichini A; Bach FH
    Hum Immunol; 1983 Nov; 8(3):195-206. PubMed ID: 6227593
    [TBL] [Abstract][Full Text] [Related]  

  • 128. Human cytotoxic lymphocytes reactive with pancreatic adenocarcinoma cells.
    Wahab ZA; Metzgar RS
    Pancreas; 1991 May; 6(3):307-17. PubMed ID: 1862066
    [TBL] [Abstract][Full Text] [Related]  

  • 129. Two distinct cytotoxic T lymphocyte subpopulations in patients with Vogt-Koyanagi-Harada disease that recognize human melanoma cells.
    Maezawa N; Yano A
    Microbiol Immunol; 1984; 28(2):219-31. PubMed ID: 6203018
    [TBL] [Abstract][Full Text] [Related]  

  • 130. Induction of tumor-specific cytotoxic T lymphocytes by immunization with autologous tumor cells and interleukin-2 gene transfected fibroblasts.
    Mackensen A; Veelken H; Lahn M; Wittnebel S; Becker D; Köhler G; Kulmburg P; Brennscheidt U; Rosenthal F; Franke B; Mertelsmann R; Lindemann A
    J Mol Med (Berl); 1997 Apr; 75(4):290-6. PubMed ID: 9151215
    [TBL] [Abstract][Full Text] [Related]  

  • 131. Generation of cytotoxic effector cells against human melanoma.
    Leong SP; Zhou YM; Granberry ME; Wang TF; Grogan TM; Spier C; White R; Mehta A; Lin AY
    Cancer Immunol Immunother; 1995 Jun; 40(6):397-409. PubMed ID: 7627996
    [TBL] [Abstract][Full Text] [Related]  

  • 132. A monoclonal cytolytic T-lymphocyte response observed in a melanoma patient vaccinated with a tumor-specific antigenic peptide encoded by gene MAGE-3.
    Coulie PG; Karanikas V; Colau D; Lurquin C; Landry C; Marchand M; Dorval T; Brichard V; Boon T
    Proc Natl Acad Sci U S A; 2001 Aug; 98(18):10290-5. PubMed ID: 11517302
    [TBL] [Abstract][Full Text] [Related]  

  • 133. The mechanism of human autologous gastric signet ring cell tumor rejection by cytotoxic T lymphocytes in the possible context of HLA-A31 molecule.
    Yasoshima T; Sato N; Hirata K; Kikuchi K
    Cancer; 1995 Mar; 75(6 Suppl):1484-9. PubMed ID: 7889479
    [TBL] [Abstract][Full Text] [Related]  

  • 134. T cell clones are killed by a thymic stromal cell monolayer following stimulation of T cell receptor with antigen and/or H-2 molecules on the monolayer.
    Matsubara H; Kosaka H; Sogo S; Maruo S; Sugihara S; Asano Y; Kohno Y; Kimoto M; Suzuki G; Ishimura K
    Int Immunol; 1990; 2(8):755-63. PubMed ID: 2150598
    [TBL] [Abstract][Full Text] [Related]  

  • 135. Rapid expansion of allospecific cytotoxic T cell clones using nonspecific feeder cell lines without further addition of exogenous IL2.
    van de Griend RJ; Bolhuis RL
    Transplantation; 1984 Oct; 38(4):401-6. PubMed ID: 6208657
    [TBL] [Abstract][Full Text] [Related]  

  • 136. Induction of syngeneic cytotoxic T lymphocytes against a B cell tumor. II. Characterization of anti-idiotypic CTL lines and clones.
    Chakrabarti D; Ghosh SK
    Cell Immunol; 1992 Oct; 144(2):443-54. PubMed ID: 1394453
    [TBL] [Abstract][Full Text] [Related]  

  • 137. Class II HLA-DR antigens on non-autoimmune human thyroid cells stimulate autologous T cells with high suppressor activity.
    Lahat N; Sheinfeld M; Sobel E; Baron E; Kraiem Z
    Autoimmunity; 1990; 8(2):125-33. PubMed ID: 2151759
    [TBL] [Abstract][Full Text] [Related]  

  • 138. Target level blocking of T-cell cytotoxicity for human malignant melanoma by monoclonal antibodies.
    Knuth A; Dippold W; Meyer zum Bueschenfelde KH
    Cell Immunol; 1984 Feb; 83(2):398-403. PubMed ID: 6198103
    [TBL] [Abstract][Full Text] [Related]  

  • 139. On the mechanism of human T cell suppression.
    Salgame P; Modlin R; Bloom BR
    Int Immunol; 1989; 1(2):121-9. PubMed ID: 2535060
    [TBL] [Abstract][Full Text] [Related]  

  • 140. Functional characterization of human alloreactive T cell clones.
    Rohowsky-Kochan C; Bonagura V; Lewison A; King DW; Suciu-Foca N
    Hum Immunol; 1984 Dec; 11(4):173-82. PubMed ID: 6239844
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.